Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aarti Pharmalabs Limited
AARTIPHARM | NSE
635.05
INR43.10
7.28%
AARTIPHARM | NSE
Loading StockChartView...
About Aarti Pharmalabs Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
635.05
Open
610.00
High
654.80
Low
610.00
Aarti Pharmalabs Limited manufactures and sells active pharmaceutical ingredients pharmaceutical intermediates new chemical entities and xanthine derivatives in India. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is based in Mumbai India.
View LessAARTIPHARM | NSE
Risk
48.8
Sharpe
-0.48
Luna's Score
55/100
Recommendation
Hold
Luna says (AARTIPHARM | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Smallcap (300M - 2B USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
59.7%1 month
48.8%3 months
41.0%6 months
40.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
24.57
Fwd. PE
-
Price to book
3.27
Debt to equity
0.16
Debt to assets
0.11
Ent. to EBITDA
14.71
Ent. to rev.
3.11
PEG
-
Other Fundamentals
EBITDA
3.97B
MarketCap
57.55B
MarketCap(USD)
617.60M
Div. yield
0.32
Op. margin
13.73
Erngs. growth
17.70
Rev. growth
21.20
Ret. on equity
13.08
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
76.95
Range1M
129.95
Range3M
232.90
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.91
Price X volume
126.45M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 14.71 | 24.85 | Cheaper |
| Ent. to Revenue | 3.11 | 11.40 | Cheaper |
| PE Ratio | 24.57 | 51.36 | Cheaper |
| Price to Book | 3.27 | 6.83 | Cheaper |
| Dividend Yield | 0.32 | 0.52 | Poor |
| Std. Deviation (3M) | 41.03 | 42.17 | Par |
| Debt to Equity | 0.16 | 0.35 | Cheaper |
| Debt to Assets | 0.11 | 0.17 | Cheaper |
| Market Cap | 57.55B | 290.82B | Emerging |
